About Us
Company Introduction
Main Subsidiaries
Solutions
Early Phase Development
Phase II-III Clinical Development
Investigator-Initiated Trials (IIT)
Therapeutic Areas
Oncology and Hematology
Autoimmune
Infectious Diseases
Neurology
Cardiovascular
Integrated Services
Strategy Consultation
Regulatory Affairs
Medical Affairs
Clinical Operations
Data Management & Statistics
TrialMaster (EDC and e-Solutions)
Clinical Pharmacology
Pharmacovigilance
IRC Service
Bioanalysis Lab
Site Management (SMO)
FSP Service
Recruitment Management
News
Perspectives
News
Contact Us
Sponsor
Job Seeker
EN
CN
Home
About Us
return
About Us
Company Introduction
Main Subsidiaries
Solutions
return
Solutions
Early Phase Development
Phase II-III Clinical Development
Investigator-Initiated Trials (IIT)
Therapeutic Areas
return
Therapeutic Areas
Oncology and Hematology
Autoimmune
Infectious Diseases
Neurology
Cardiovascular
Integrated Services
return
Integrated Services
Strategy Consultation
Regulatory Affairs
Medical Affairs
Clinical Operations
Data Management & Statistics
TrialMaster (EDC and e-Solutions)
Clinical Pharmacology
Pharmacovigilance
IRC Service
Bioanalysis Lab
Site Management (SMO)
FSP Service
Recruitment Management
News
return
News
Perspectives
News
Contact Us
return
Contact Us
Sponsor
Job Seeker
Home
>
News
>
Perspectives
Perspectives
Perspectives
News
year
2025
2024
2023
2022
2021
2020
2019
Search
Rrecommend
2025-02-19
News
UnionClin Signs as Key Project in Pudong Zhangjiang Park,Bolster High-Quality Development of the New Area's Biopharmaceutical Industry
2025-01-16
News
Union Laiya Proudly Becomes a CDISC Corporate Member, Jointly Building a New Future for Clinical Research Data
2023-04-07
Perspectives
四代EGFR抑制剂数据大盘点
表皮生长因子受体(简称为EGFR、ErbB-1或HER1)是受体酪氨酸激酶(RTK)超家族的一员,由外显子边界和相关的细胞外、跨膜和细胞内蛋白质结构域组成,EGFR参与多种信号通路并调节多种细胞功能。
<<
8
9
10
>>
Information
Business Enquiry
+8621-58301389